Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis
出版年份 2020 全文链接
标题
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis
作者
关键词
-
出版物
HEPATOLOGY
Volume 73, Issue 4, Pages 1290-1306
出版商
Wiley
发表日期
2020-11-01
DOI
10.1002/hep.31609
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker
- (2020) Guido Alessandro Baselli et al. GUT
- The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
- (2020) Divya P. Kumar et al. Scientific Reports
- PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice
- (2019) Yang Wang et al. HEPATOLOGY
- Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
- (2019) Soumik BasuRay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
- (2019) Daniel Lindén et al. Molecular Metabolism
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells
- (2017) Francesca Virginia Bruschi et al. HEPATOLOGY
- The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation
- (2017) Soumik BasuRay et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
- (2017) Sophie Cazanave et al. Scientific Reports
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
- (2016) Amon Asgharpour et al. JOURNAL OF HEPATOLOGY
- Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
- (2016) Panu K. Luukkonen et al. JOURNAL OF HEPATOLOGY
- Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial
- (2015) Eleonora Scorletti et al. JOURNAL OF HEPATOLOGY
- Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease
- (2015) Tommy Pacana et al. PLoS One
- The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
- (2015) Christopher Day et al. SEMINARS IN LIVER DISEASE
- PUFAs: Structures, Metabolism and Functions
- (2015) Anna Wiktorowska-Owczarek et al. Advances in Clinical and Experimental Medicine
- Metabolic profiling reveals that PNPLA3 induces widespread effects on metabolism beyond triacylglycerol remodeling in Huh-7 hepatoma cells
- (2014) Hae-Ki Min et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis
- (2014) S C Cazanave et al. CELL DEATH AND DIFFERENTIATION
- Pnpla3I148Mknockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
- (2014) Eriks Smagris et al. HEPATOLOGY
- PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
- (2014) Carlo Pirazzi et al. HUMAN MOLECULAR GENETICS
- PNPLA3 mediates hepatocyte triacylglycerol remodeling
- (2014) Hanna Ruhanen et al. JOURNAL OF LIPID RESEARCH
- PNPLA3 I148M polymorphism and progressive liver disease
- (2013) Paola Dongiovanni WORLD JOURNAL OF GASTROENTEROLOGY
- Human thyroxine binding globulin (TBG) promoter directs efficient and sustaining transgene expression in liver-specific pattern
- (2012) Zhonghai Yan et al. GENE
- Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
- (2012) Carlo Pirazzi et al. JOURNAL OF HEPATOLOGY
- PNPLA3variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease
- (2010) Elizabeth K. Speliotes et al. HEPATOLOGY
- The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease
- (2010) Yaron Rotman et al. HEPATOLOGY
- Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
- (2010) Luca Valenti et al. HEPATOLOGY
- Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome
- (2010) Mahesh K. Basantani et al. JOURNAL OF LIPID RESEARCH
- A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
- (2009) Shaoqing He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started